Immune-checkpoint inhibition as first-line therapy for Hodgkin lymphoma

Alvaro J. Alencar, Craig H. Moskowitz

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)599-600
Number of pages2
JournalNature Reviews Clinical Oncology
Volume16
Issue number10
DOIs
StatePublished - Oct 1 2019

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Immune-checkpoint inhibition as first-line therapy for Hodgkin lymphoma'. Together they form a unique fingerprint.

  • Cite this